Unlock the Full Potential of Your Cell Therapy

May 04, 2022

Fabian Gerlinghaus recognized in Medicine Maker Power List 2022

Fabian Gerlinghaus recognized in Medicine Maker Power List 2022

May 4th, 2022 – South San Francisco – Today, Cellares Co-Founder and CEO, Fabian Gerlinghaus was recognized in the 2022 Power List, celebrating the most Influential Medicine Makers of the past year. This marks the second year in a row that he has been featured by The Medicine Maker team.

The Medicine Maker 2022 Power List recognizes the top 10 leaders in small molecules, biopharmaceuticals, and advanced therapy – 30 amazing individuals in total.  The Medicine Maker has published its Power List annually since 2015.

Cellares Co-Founder and CEO, Fabian Gerlinghaus said, “Once again I am humbled to have been selected by The Medicine Maker for their Power List 2022 in the area of Advanced Medicine, alongside other visionaries in cell and gene therapy. It is truly inspiring to be in the company of industry leaders like Bruce Levine, Miguel Forte, Massimo Dominici, and Jacques Galipeau.  At Cellares we are building a talented, skilled, and dedicated team, with a shared goal of creating the future of cell therapy manufacturing.  I am so lucky to be leading such an amazing team!  This recognition is once again validation of their tremendous work.  Together, we look forward to continuing our mission and accelerating access to life-saving cell therapies.

A link to the entire list can be found here.

About The Medicine Maker

The Medicine Maker is a leading publication for professionals in the fields of drug development and manufacturing. Through its many resources  ̶  website, newsletters, webinars, social channels, monthly print magazine, and videos  ̶  The Medicine Maker gives its vast audience of readers a truly global and multimedia platform from which to learn, communicate, network, and further the field of small molecule, biologics, and advanced therapies development, manufacturing, and supply.